Bhramar Mukherjee appointed associate director for population science at University of Michigan Comprehensive Cancer Center

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

BHRAMAR MUKHERJEE was appointed associate director for population science research at The University of Michigan Comprehensive Cancer Center, effective Jan. 15, 2016.

Mukherjee is the John D. Kalbfleisch Collegiate professor of biostatistics and a professor of epidemiology at the U-M School of Public Health. She also serves as the associate chair for biostatistics.

In her new role, she will oversee the center’s research on screening, detection and prevention, as well as research on outcomes, disparities and new models of cancer care delivery.

Mukherjee joined the University of Michigan faculty in 2006. She has received the U-M School of Public Health’s Excellence in Teaching Award and was the recipient this year of the University of Michigan’s Faculty Recognition Award. She is the founding director of a cross-disciplinary summer institute at the School of Public Health to train undergraduates at the intersection of big data and human health. She is also an elected fellow of the American Statistical Association.

Her cancer research has focused on how the interaction between genes and the environment impacts cancer risk. She has studied the roles of diet, physical activity and lifestyle factors, and their interplay with the genetic architecture of an individual.

The associate director for population science position was last held by Stephen Gruber, who is now the director of the University of Southern California Norris Comprehensive Cancer Center.

Table of Contents

YOU MAY BE INTERESTED IN

The U.S. House of Representatives Jan. 22 passed a three-bill minibus package that is expected to be the grand finale of the drama of the fiscal year 2026 appropriations process. The package, which funds the HHS as well as the departments of Defense, Transportation, Housing and Urban Development, Labor, and Education, gives NIH and NCI modest raises over FY25, and nullifies several  aggressive cuts the White House had proposed for NIH.

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login